System-Specific Biopharmaceuticals

Fortress Biotech Pref Share FBIOP 9.375 15/12/22

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 released FY2025 9 Months earnings on November 14, 2025 (EST), actual revenue USD 47.18M, actual EPS USD 0.0792

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 released FY2024 9 Months earnings on November 14 (EST), actual revenue USD 42.56 M, actual EPS USD -2.533

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 released FY2020 Q2 earnings on August 10, 2020 (EST), with actual revenue of 9.457M USD and EPS of -2.9133

Freecast

Cuprina

U-BX Tech

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Defiance Pure Space Dly 2X Strat ETF

VS MEDIA

Everbright Digital

Park Ha Biological Tech

Friedman Industries

Defiance Daily Target 2X Short ASTS ETF

FBIOP

Earnings Watch

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 8-K: FY2026 Q1 Revenue: USD 16.04 M

FNCL

FBIO

<p>Fortress Value Acquisition V, a SPAC by Fortress Investment Group, has priced its IPO at $250 million, offering 25 million shares at $10 each. Unlike typical SPACs, it is offering shares without attached warrants. The SPAC is led by Andrew McKnight, Andrew Stroud, and Micah Kaplan, with John Konawalik as CFO. Previous SPACs from Fortress include Fortress Value Acquisition IV and III, both of which liquidated in 2022. Fortress Value Acquisition V plans to list on Nasdaq under the symbol FVAV, with Deutsche Bank as the sole bookrunner.</p>

RenaissanceCapital

ISHRS Us Brokers & Sec Exchg

Financial Select Sector SPDR Fund

VG Financial

Fidelity MSCI Financials Index

Fortress Biotech

SPAC Fortress Investment Group's Fortress Value Acquisition V prices $250 million IPO

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 10-Q: FY2025 Q3 Revenue: USD 17.63 M

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 8-K: FY2025 Q3 Revenue: USD 17.63 M

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 10-Q: FY2025 Q2 Revenue: USD 16.41 M

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 8-K: FY2025 Q2 Revenue: USD 16.41 M

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 10-Q: FY2025 Q1 Revenue: USD 13.14 M

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 8-K: FY2025 Q1 Revenue: USD 13.14 M

Fortress Biotech Pref Share FBIOP 9.375 15/12/22(FBIOP.US)

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 8-K: FY2026 Q1 Revenue: USD 16.04 M

SPAC Fortress Investment Group's Fortress Value Acquisition V prices $250 million IPO

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 10-Q: FY2025 Q3 Revenue: USD 17.63 M

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 8-K: FY2025 Q3 Revenue: USD 17.63 M

Fortress Biotech Pref Share FBIOP 9.375 15/12/22 | 10-Q: FY2025 Q2 Revenue: USD 16.41 M